Patent ID: 6197749
Filing Date: 2001-03-06
Classification: A23L,A61K

Abstract:
A method of treating cachectic condition caused by cancers, diabetes, gastrointestinal inflammatory diseases, chronic rheumatoid arthritis, hepatitis, hepatic cirrhosis, hypersensitive interstitial pneumonia, pulmonary fibrosis, or autoimmune inflammatory diseases, comprising administering to a patient in thereof an effective amount of a composition comprising a cystine derivative represented by formula (I): ##STR2##whereinR.sup.1 and R.sup.2, independently from each other, represent an alkyl group; andR.sup.3 and R.sup.4, independently from each other, represent an acyl group or a peptidyl group,wherein said cystine derivative reduces the content of reductive glutathione in macrophages, and suppresses cellular immune responses in said patient.